Toll2011 Meeting, Decoding Innate Immunity

Toll2011会议，解码先天免疫

• 批准号: 8130053
• 负责人: Robert William Finberg
• 金额: $ 1.2万
• 依托单位: UNIV OF MASSACHUSETTS MED SCH WORCESTER
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-03-01 至 2012-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8130053
• 关键词: Americas; Area; Asia; Bacteria; Biological Models; Brazil; Clinical Research; Clinical Trials; Collaborations; Country; Development; Educational workshop; Environment; Europe; Evolution; Feedback; Future; Goals; Hearing; Immunology; Individual; Institution; Italy; Mind; Natural Immunity; Parasites; Participant; Physicians; Portugal; Research; Research Personnel; Science; Scientist; Series; Signal Pathway; Signal Transduction; Toll-like receptors; Virus; Virus Diseases; Work; adaptive immunity; career; fungus; innovation; lectures; meetings; microbial; novel; novel therapeutics; pathogen; peer; posters; programs; research study; symposium; therapeutic development

DESCRIPTION (provided by applicant): This application seeks support for Toll2011, the fourth in a series of meetings focused on research advances in innate immunity. The meeting is planned for May 4-7, 2011 in Riva del Garda, Italy and follows meetings in Taormina, Italy (2004), Salvador, Brazil (2006) and Cascais/Lisbon, Portugal (2008). The meeting in 2008 had over 500 participants, and the maximum amount of participants in 2011 will be close to 600. The meetings initially had a strong emphasis on recognition of microbial components (from viruses, bacteria, parasites, fungi) and signaling via Toll-like receptors, but in later years the themes have expanded to reflect a number of new signaling pathways (such as inflammasome activation) in host sensing of pathogens. Results are presented on diverse topics such as the interface between innate and adaptive immunity, model systems, evolution of innate immunity and clinical studies. Many speakers are from academic institutions in Europe, Asia, USA and other countries in the Americas, including speakers presenting on development of therapeutics related to innate immunity. The meeting intends to present cutting-edge science on many aspects related to innate immunity. PUBLIC HEALTH RELEVANCE: The study of innate immunity has been rapidly evolving and new challenges and discoveries are constantly being identified. The Toll2011 Meeting E Decoding innate immunity will bring clinicians and scientists together to exchange, discuss, and evaluate recent discoveries in the field of innate immunity and related topics. The conference will entail the following: lectures from distinguished scholars in several research aspects of innate immunity, poster sessions for young investigators to communicate their findings, and workshops where experts will debate the important topics of the day with audience participation. The goal of this meeting is to enhance understanding and disseminate available information on new developments towards understanding the underlying causes of innate immunity. The conference will also define the significant remaining scientific questions that need to be answered in order to advance future treatments for viral diseases.

描述（由申请人提供）：本申请寻求对Toll2011的支持，这是一系列集中于先天免疫研究进展的会议中的第四次。该会议计划于2011年5月4日至7日在意大利的里瓦·德尔加尔达（Riva del Garda）举​​行，并在意大利陶尔米纳（Taormina）举行的会议（2004年），萨尔瓦多（Salvador），巴西（2006）和葡萄牙的卡斯卡斯（Cascais）/里斯本（Cascais/Lisbon）（2008年）。 2008年的会议有超过500名参与者，2011年的最高参与者将接近600人。最初，会议非常强调对微生物成分（来自病毒，细菌，寄生虫，寄生虫，真菌）的信号传导，并通过收费受体样受体发出信号，但在后来的几年中，这些主机已经扩展到了一定的信号通道（例如，启动了一系列的传播）（例如，发出了一定的通向启动的启动），这是一系列发出的。结果介绍了各种主题，例如先天和适应性免疫之间的接口，模型系统，先天免疫的演变和临床研究。许多发言人来自欧洲，亚洲，美国和美洲其他国家的学术机构，包括有关与先天免疫有关的治疗学发展的发言人。会议打算就与先天免疫相关的许多方面介绍尖端科学。 公共卫生相关性：对先天免疫的研究一直在迅速发展，并且不断发现新的挑战和发现。 TOLL2011会议E解码先天免疫将使临床医生和科学家聚集在一起交流，讨论和评估先天免疫和相关主题的最新发现。会议将需要以下内容：来自先天免疫的几个研究方面的杰出学者的讲座，年轻调查人员传达他们的发现的海报会议，以及专家将与观众参与辩论当天重要主题的讲习班。这次会议的目的是增强有关新发展的理解和传播信息，以理解先天免疫的根本原因。会议还将定义需要回答的剩余剩余科学问题，以推动对病毒疾病的未来治疗。